Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity

被引:131
|
作者
Feng, HP [1 ]
Zeng, Y [1 ]
Whitesell, L [1 ]
Katsanis, E [1 ]
机构
[1] Univ Arizona, Steele Mem Childrens Res Ctr, Dept Pediat, Tucson, AZ 85724 USA
关键词
D O I
10.1182/blood.V97.11.3505
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In attempting to develop effective anticancer immunotherapies, the relative ability of apoptotic cells to induce an immune response remains an important but controversial consideration. A novel gene-transfer approach was used by which rapid induction of pure apoptosis can be selectively achieved in a transfected tumor cell population following exposure to a semisynthetic dimerizing ligand, AP20187, Inoculation of BALB/c mice with apoptotic and viable 12B1-D1 leukemia cells, at a 12:1 ratio subcutaneously, led to early tumor growth. Heat stress upregulated the expression of membrane heat shock proteins (HSP72 and HSP60) on apoptotic 12B1-D1 cells, and stressed apoptotic cells were capable of generating a T-cell-mediated specific antitumor response. Pulsing of stressed apoptotic leukemia cells onto syngeneic dendritic cells resulted largely in rejection of coinjected viable 12B1-D1 cells. Mice rejecting the primary 12B1-D1 inoculum were immune to the same but not to a different leukemia challenge, Our findings indicate that tumor immunogenicity is dependent on whether cells are stressed before apoptosis induction and suggest that the immune system is capable of distinguishing between stressed and nonstressed cells undergoing programmed cell death.(Blood.2001;97:3505-3512) (C) 2001 by The American Society of Hematology.
引用
收藏
页码:3505 / 3512
页数:8
相关论文
共 50 条
  • [21] Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms
    Okada, H
    Tahara, H
    Shurin, MR
    Attanucci, J
    Giezeman-Smits, KM
    Fellows, WK
    Lotze, MT
    Chambers, WH
    Bozik, ME
    INTERNATIONAL JOURNAL OF CANCER, 1998, 78 (02) : 196 - 201
  • [22] HUMAN TUMOR-SPECIFIC IMMUNITY - HAS IT ARRIVED
    LOBUGLIO, AF
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (24) : 1980 - 1981
  • [23] AUGMENTATION OF TUMOR-SPECIFIC IMMUNITY WITH IMMUNE RNA
    DECKERS, PJ
    WANG, BS
    STUART, PA
    MANNICK, JA
    TRANSPLANTATION PROCEEDINGS, 1975, 7 (02) : 259 - 263
  • [24] Boosting Tumor-Specific Immunity Using PDT
    Maeding, Nicole
    Verwanger, Thomas
    Krammer, Barbara
    CANCERS, 2016, 8 (10)
  • [25] Radiotherapy supports protective tumor-specific immunity
    Gupta, Anurag
    Sharma, Anu
    von Boehmer, Lotta
    Surace, Laura
    Knuth, Alexander
    van den Broek, Maries
    ONCOIMMUNOLOGY, 2012, 1 (09): : 1610 - 1611
  • [26] EFFECTS OF SPLENECTOMY ON THE DEVELOPMENT OF TUMOR-SPECIFIC IMMUNITY
    SCHWARZ, RE
    HISERODT, JC
    JOURNAL OF SURGICAL RESEARCH, 1990, 48 (05) : 448 - 453
  • [27] LYMPHOCYTE CULTURE FOR DETECTION OF TUMOR-SPECIFIC IMMUNITY
    NAGEL, GA
    SENN, HJ
    JUNGI, WF
    MAYR, AC
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1972, 102 (33) : 1179 - &
  • [28] Role of monoclonal antibodies in tumor-specific immunity
    Nicodemus, Christopher F.
    Smith, L. Mary
    Schultes, Birgit C.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (03) : 331 - 343
  • [29] Trifunctional Bispecific Antibodies Induce Tumor-Specific T Cells and Elicit a Vaccination Effect
    Eissler, Nina
    Ruf, Peter
    Mysliwietz, Josef
    Lindhofer, Horst
    Mocikat, Ralph
    CANCER RESEARCH, 2012, 72 (16) : 3958 - 3966
  • [30] INFLUENCE OF TUMOR ANTIGEN ON MAINTENANCE VERSUS DEPRESSION OF TUMOR-SPECIFIC IMMUNITY
    VAAGE, J
    CANCER RESEARCH, 1973, 33 (03) : 493 - 503